Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
245.44
+6.57 (2.75%)
Dec 20, 2024, 4:00 PM EST - Market closed
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of $31.66 billion as of December 20, 2024. Its market cap has increased by 42.31% in one year.
Market Cap
31.66B
Enterprise Value
31.60B
1-Year Change
42.31%
Ranking
Category
Stock Price
$245.44
Market Cap Chart
Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $31.66B, an increase of 23,349.69%. That is a compound annual growth rate of 30.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 31.66B | 31.79% |
| Dec 29, 2023 | 24.02B | -17.84% |
| Dec 30, 2022 | 29.24B | 44.16% |
| Dec 31, 2021 | 20.28B | 34.32% |
| Dec 31, 2020 | 15.10B | 17.60% |
| Dec 31, 2019 | 12.84B | 74.32% |
| Dec 31, 2018 | 7.37B | -37.48% |
| Dec 29, 2017 | 11.78B | 266.69% |
| Dec 30, 2016 | 3.21B | -59.72% |
| Dec 31, 2015 | 7.98B | 6.90% |
| Dec 31, 2014 | 7.46B | 82.96% |
| Dec 31, 2013 | 4.08B | 326.36% |
| Dec 31, 2012 | 956.60M | 174.73% |
| Dec 30, 2011 | 348.20M | -16.32% |
| Dec 31, 2010 | 416.10M | -43.53% |
| Dec 31, 2009 | 736.80M | -28.05% |
| Dec 31, 2008 | 1.02B | -13.48% |
| Dec 31, 2007 | 1.18B | 71.64% |
| Dec 29, 2006 | 689.60M | 94.42% |
| Dec 30, 2005 | 354.70M | 136.47% |
| Dec 31, 2004 | 150.00M | 11.11% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veeva Systems | 35.48B |
| GE HealthCare Technologies | 35.43B |
| IQVIA Holdings | 34.79B |
| ResMed | 34.04B |
| IDEXX Laboratories | 33.62B |
| Centene | 30.10B |
| DexCom | 29.53B |
| Cardinal Health | 28.34B |